Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem ; 28(13): 115523, 2020 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-32362385

RESUMO

Eukaryotic translation initiation factor 4E (eIF4E) is overexpressed in many cancers deregulating translational control of the cell cycle. mRNA 5' cap analogs targeting eIF4E are small molecules with the potential to counteract elevated levels of eIF4E in cancer cells. However, the practical utility of typical cap analogs is limited because of their reduced cell membrane permeability. Transforming the active analogs into their pronucleotide derivatives is a promising approach to overcome this obstacle. 7-Benzylguanosine monophosphate (bn7GMP) is a cap analog that has been successfully transformed into a cell-penetrating pronucleotide by conjugation of the phosphate moiety with tryptamine. In this work, we explored whether a similar strategy is applicable to other cap analogs, particularly phosphate-modified 7-methylguanine nucleotides. We report the synthesis of six new tryptamine conjugates containing N7-methylguanosine mono- and diphosphate and their analogs modified with thiophosphate moiety. These new potential pronucleotides and the expected products of their activation were characterized by biophysical and biochemical methods to determine their affinity towards eIF4E, their ability to inhibit translation in vitro, their susceptibility to enzymatic degradation and their turnover in cell extract. The results suggest that compounds containing the thiophosphate moiety may act as pronucleotides that release low but sustainable concentrations of 7-methylguanosine 5'-phosphorothioate (m7GMPS), which is a translation inhibitor with in vitro potency higher than bn7GMP.


Assuntos
Fator de Iniciação 4E em Eucariotos/genética , Guanina/análogos & derivados , Nucleotídeos/química , Fosfatos/química , Triptaminas/química , Endorribonucleases/metabolismo , Variação Genética , Guanina/química , Guanosina/análogos & derivados , Guanosina/química , Humanos , Modelos Moleculares , Proteínas do Tecido Nervoso/metabolismo , Motivos de Nucleotídeos , Nucleotídeos/genética , Biossíntese de Proteínas , Análogos de Capuz de RNA/química , Análogos de Capuz de RNA/genética , RNA Mensageiro/química , RNA Mensageiro/genética
2.
Chemistry ; 26(49): 11266-11275, 2020 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-32259329

RESUMO

In eukaryotes, mature mRNA is formed through modifications of precursor mRNA, one of which is 5' cap biosynthesis, involving RNA cap guanine-N7 methyltransferase (N7-MTase). N7-MTases are also encoded by some eukaryotic viruses and facilitate their replication. N7-MTase inhibitors have therapeutic potential, but their discovery is difficult because long RNA substrates are usually required for activity. Herein, we report a universal N7-MTase activity assay based on small-molecule fluorescent probes. We synthesized 12 fluorescent substrate analogues (GpppA and GpppG derivatives) varying in the dye type, dye attachment site, and linker length. GpppA labeled with pyrene at the 3'-O position of adenosine acted as an artificial substrate with the properties of a turn-off probe for all three tested N7-MTases (human, parasite, and viral). Using this compound, a N7-MTase inhibitor assay adaptable to high-throughput screening was developed and used to screen synthetic substrate analogues and a commercial library. Several inhibitors with nanomolar activities were identified.


Assuntos
Avaliação Pré-Clínica de Medicamentos , Ensaios Enzimáticos , Inibidores Enzimáticos/isolamento & purificação , Inibidores Enzimáticos/farmacologia , Ensaios de Triagem em Larga Escala , Metiltransferases/metabolismo , Capuzes de RNA/metabolismo , Guanina/análogos & derivados , Guanina/metabolismo , Humanos , Metiltransferases/antagonistas & inibidores , Capuzes de RNA/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA